SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals. (Q34063645)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals.
scientific article

    Statements

    SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit